Kiniksa Pharmaceuticals International Plc (KNSA)

$20.21 -0.33 (-1.58%)
Market Cap 1.47B
Revenue (ttm) 423.24M
Net Income (ttm) -43.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 28.65
Profit Margin -10.20%
Debt to Equity Ratio 0.00
Volume 529,800
Avg Vol 637,852
Day's Range N/A - N/A
Shares Out 72.64M
Stochastic %K 64%
Beta 0.31
Analysts Strong Sell
Price Target $35.86

Latest News on KNSA

Big Pipeline Updates From Kiniksa Pharmaceuticals

Feb 25, 2025, 4:14 PM EST - 7 weeks ago

Big Pipeline Updates From Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 10:53 AM EST - 7 weeks ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

Feb 25, 2025, 7:30 AM EST - 7 weeks ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy

Feb 25, 2025, 7:29 AM EST - 7 weeks ago

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Feb 20, 2025, 4:01 PM EST - 2 months ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

Jan 13, 2025, 7:30 AM EST - 3 months ago

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:01 PM EST - 3 months ago

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

Nov 26, 2024, 4:01 PM EST - 5 months ago

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Nov 12, 2024, 4:01 PM EST - 5 months ago

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 11:45 AM EDT - 6 months ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Oct 29, 2024, 7:30 AM EDT - 6 months ago

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Oct 22, 2024, 4:01 PM EDT - 6 months ago

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Aug 28, 2024, 4:01 PM EDT - 8 months ago

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat

Jul 24, 2024, 5:38 AM EDT - 9 months ago

Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript

Jul 23, 2024, 1:30 PM EDT - 9 months ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

Jul 23, 2024, 7:30 AM EDT - 9 months ago

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

Jul 16, 2024, 4:01 PM EDT - 9 months ago

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's Disease

Jul 9, 2024, 8:00 AM EDT - 10 months ago

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's Disease

Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative

Jun 17, 2024, 8:30 AM EDT - 10 months ago

Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Jun 4, 2024, 4:01 PM EDT - 11 months ago

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

May 7, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape

Apr 24, 2024, 1:34 PM EDT - 1 year ago

Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape

Kiniksa Pharmaceuticals Ltd. (KNSA) Q1 2024 Earnings Call Transcript

Apr 23, 2024, 1:59 PM EDT - 1 year ago

Kiniksa Pharmaceuticals Ltd. (KNSA) Q1 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Apr 23, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Apr 16, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

Apr 2, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

Kiniksa Pharmaceuticals Ltd. (KNSA) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 11:58 AM EST - 1 year ago

Kiniksa Pharmaceuticals Ltd. (KNSA) Q4 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Feb 28, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Feb 21, 2024, 4:01 PM EST - 1 year ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Kiniksa Pharmaceuticals: Early 2024 Corporate Update A Mixed Bag

Jan 5, 2024, 4:29 PM EST - 1 year ago

Kiniksa Pharmaceuticals: Early 2024 Corporate Update A Mixed Bag

Kiniksa Pharmaceuticals Provides Corporate Update

Jan 4, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Provides Corporate Update

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 4:01 PM EST - 1 year ago

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Kiniksa Pharmaceuticals: Arcalyst Performs While KPL-404 Advances Toward Early 2024 Readout

Nov 3, 2023, 11:07 AM EDT - 1 year ago

Kiniksa Pharmaceuticals: Arcalyst Performs While KPL-404 Advances Toward Early 2024 Readout

Kiniksa Pharmaceuticals Ltd (KNSA) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 2:35 PM EDT - 1 year ago

Kiniksa Pharmaceuticals Ltd (KNSA) Q3 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution

Oct 31, 2023, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

Oct 24, 2023, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up

Jul 27, 2023, 10:57 AM EDT - 1 year ago

Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up

Kiniksa Pharmaceuticals Ltd (KNSA) Q2 2023 Earnings Call Transcript

Jul 25, 2023, 12:22 PM EDT - 1 year ago

Kiniksa Pharmaceuticals Ltd (KNSA) Q2 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution

Jul 25, 2023, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals: Autoimmune Therapy Offers Attractive Prospects At Current Price

Jul 19, 2023, 3:25 PM EDT - 1 year ago

Kiniksa Pharmaceuticals: Autoimmune Therapy Offers Attractive Prospects At Current Price

Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023

Jul 17, 2023, 8:00 AM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023

Kiniksa Pharmaceuticals: A Somewhat Complicated Story

Jun 9, 2023, 12:32 PM EDT - 2 years ago

Kiniksa Pharmaceuticals: A Somewhat Complicated Story

Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Jun 6, 2023, 4:01 PM EDT - 2 years ago

Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 2023 Earnings Call Transcript

May 6, 2023, 12:32 PM EDT - 2 years ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution

May 2, 2023, 7:30 AM EDT - 2 years ago

Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023

May 1, 2023, 4:01 PM EDT - 2 years ago

Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 5:35 PM EST - 2 years ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 2022 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution

Feb 28, 2023, 8:00 AM EST - 2 years ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023

Feb 27, 2023, 4:01 PM EST - 2 years ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023

Kiniksa: Steady Progress With Arcalyst, But Still Pretty Unexciting

Feb 19, 2023, 8:28 AM EST - 2 years ago

Kiniksa: Steady Progress With Arcalyst, But Still Pretty Unexciting